Frederick Locke, MD, Program Co-Leader, Immunology Moffitt Cancer Center, discusses How To Integrate CAR-T With Stem Cell Transplant. At The…
Browsing: Lymphoma
Andre Goy, MD, Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical…
Julie Vose, MD, Professor, Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center, Discusses Improvements Made In…
Jasmine Zain, MD, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope,…
Andre Goy, MD, Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical…
Tatyana Feldman, MD, Hematology & Oncology, Hackensack University Medical Center, John Theurer Cancer Center, discusses Improvements In The Treatment Of…
Lorenz Trumper, MD, Professor of Internal Medicine and Chairman of the Department of Hematology and Oncology, Georg August University of…
Jeff Sharman, MD, Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, discusses…
Swaminathan P. Iyer, MD, Professor, Department of Lymphoma and Myeloma, Division of Cancer Medicine Division, MD Anderson Cancer Center, discusses…
Sattva Neelapu, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicines, MD Anderson Cancer Center, discusses The Use Of…
Jasmine Zain, MD, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope,…
Andre Goy, MD Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical…
Jasmine Zain, MD, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope,…
Andre Goy, MD Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical…
Julie Vose, MD Professor Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center, discusses Does Polatuzumab Improve…
Sattva Neelapu, MD Department of Lymphoma and Myeloma, Division of Cancer Medicines, MD Anderson Cancer Center, discusses The Future Of…
Lorenz Trumper, MD Professor of Internal Medicine and Chairman of the Department of Hematology and Oncology, Georg August University of…
Swaminathan P. Iyer, MD Professor, Department of Lymphoma and Myeloma, Division of Cancer Medicine Division, MD Anderson Cancer Center, discusses…
Tatyana Feldman, MD Hematology & Oncology, Hackensack University Medical Center, John Theurer Cancer Center, discusses The Unmet Needs In Peripheral…
Lorenz Trumper, MD Professor of Internal Medicine and Chairman of the Department of Hematology and Oncology, Georg August University of…
Julie Vose, MD Professor, Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center discusses Are CAR-T Therapies…
Swaminathan Padmanabhan Iyer, MD Professor, Department of Lymphoma and Myeloma, MD Anderson Cancer Center discusses Game Changing ECHELON-2 Study For…
Frederick Locke, MD Program Co-Leader, Immunology Moffitt Cancer Center Discusses Using CAR-T Therapies In Leukemia & Lymphoma. At The 60th…
Andre Goy, MD Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical…
Elizabeth Budde, MD Assistant Professor in the Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Discusses CAR-T Therapies…
Sattva Neelapu, MD Department of Lymphoma and Myeloma, Division of Cancer Medicines, MD Anderson Cancer Center Discusses ZUMA-1 Two-Year Follow-Up…
Jasmine Zain, MD Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T Cell Lymphoma Program, City of Hope…
Michael Wang, M.D. Professor in the department of Lymphoma & Myeloma at MD Anderson Discusses Metabolic Reprogramming At The 60th…
Michelle Dawson Franchise Head Hematology, US Medical Affairs at AstraZeneca Discusses Acalabrutinib Key Clinical Data At The 60th ASH Annual…
Mohamed Mohty, M.D., PhD Professor of Hematology and head of the Hematology and Cellular Therapy Department at the Saint-Antoine Hospital…
Michael Wang, M.D. Professor in the department of Lymphoma & Myeloma at MD Anderson Discusses Acalabrutinib Trial follow Up At…
Michael Wang, M.D. Professor in the department of Lymphoma & Myeloma at MD Anderson Discusses Acalabrutinib Therapy: Infection Rate &…
Sattva Neelapu, M.D. Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston,…
Sattva Neelapu, M.D. Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston,…
Mohamed Mohty, M.D., PhD Professor of Hematology and head of the Hematology and Cellular Therapy Department at the Saint-Antoine Hospital…
Rajat Bannerji, MD, PhD Associate Professor of Medicine Division of Hematology Oncology Robert Wood Johnson Medical School Rutgers, The State…
Earn CME: https://naccme.com/program/7317 In this presentation from the ‘Evaluating the Role of PI3K Inhibitors in Follicular Lymphoma: Highlighting the Diversity…
Earn CME: https://naccme.com/program/7317 In this presentation from the ‘Evaluating the Role of PI3K Inhibitors in Follicular Lymphoma: Highlighting the Diversity…
Earn CME: https://naccme.com/program/7316 In this presentation from the ‘Surviving and Thriving with B-Cell Malignancies: Surveying an Ever-Evolving Landscape symposium, Dr.…
Earn CME: https://naccme.com/program/7316 In this presentation from the ‘Surviving and Thriving with B-Cell Malignancies: Surveying an Ever-Evolving Landscape symposium, Dr.…
Earn CME: https://naccme.com/program/7315 In this presentation from the ‘CAR-T for Lymphomas: Cultivating a Cure, Controlling a Crisis symposium, Nurse Rita…
Earn CME: https://naccme.com/program/7315 In this presentation from the ‘CAR-T for Lymphomas: Cultivating a Cure, Controlling a Crisis symposium, Dr. Caron…
Earn CME: https://naccme.com/program/7315 In this presentation from the ‘CAR-T for Lymphomas: Cultivating a Cure, Controlling a Crisis symposium, Dr. Caron…
Earn CME: https://naccme.com/program/7309 In this Key Insights activity, Drs. Morton Coleman and John P. Leonard discuss highlights in lymphoma from…
At the 2018 British Oncology Pharmacy Association (BOPA) Annual Symposium, Simon Cheesman, MRPharmS, of University College London, London, UK, presented…
The field of blood cancer therapeutics has seen enormous progression. Here, Steven Rosen, MD, from the City of Hope, Duarte,…
Speaking from the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting, held in Nice, France, Bianca Santomasso, MD, PhD, of…
Maintenance therapy options for cutaneous T-cell lymphomas could be improved. Here, Rudolf Stadler, MD, PhD, of the University Medical Center…
Establishing a registry and prognostic index for mycosis fungoides, the most common type of cutaneous T-cell lymphoma (CTCL), and Sézary…
Our understanding of stem cells has improved exponentially since their discovery, transforming our treatment of hematological malignancies and other diseases.…